Adjuvant treatment of clinical Stage I seminoma: Is a single course of carboplatin sufficient?

Urology

Volumn 55, Issue 1, 2000, Pages 102-106

  Dieckmann, Klaus Peter ^a,b   Brüggeboes, Bernd ^c   Pichlmeier, Uwe ^d   Küster, Jens ^e   Müllerleile, Ulrich ^f   Bartels, Henning ^e  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b ALBERTINEN KRANKENHAUS   (Germany)

^c Urologische Praxis ^*  (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e Urologische Abt Evangelisches K   (Germany)

^f Abt Onkologie Allgemeines K   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FOLLOW UP; GONAD DYSFUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEMINOMA; SURVIVAL RATE; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; SEMINOMA; SURVIVAL RATE; TESTICULAR NEOPLASMS;

EID: 17544399759     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00376-3     Document Type: Article

References (28)

1. Zagars G.K. Stage I testicular seminoma following orchidectomy - to treat or not to treat. Eur J Cancer. 29A:1993;1923-1924.
2. Schmidtberger H., Bamberg M. Therapieoptionen bei testikulären Seminomen in den frühen Stadien. Strahlenther Onkol. 171:1995;125-139.
3. Warde P., Gospodarowicz M.K., Panzarella T., et al. Stage I testicular seminoma results of adjuvant irradiation and surveillance . J Clin Oncol. 13:1995;2255-2262.
4. Fossa S.D., Aass N., Kaalhus O. Radiotherapy for testicular seminoma stage I treatment results and long-term post-irradiation morbidity in 365 patients . Int J Radiat Oncol Biol Phys. 16:1989;383-388.
5. Mason M.D., Jones W.G. Treatment of stage I seminoma more choices, more dilemmas . Clin Oncol. 9:1997;210-212.
6. Boyer M., Raghavan D. Toxicity of treatment of germ cell tumors. Semin Oncol. 19:1992;128-142.
7. Horwich A., Alsanjari N., Hern R.A., et al. Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer. 65:1992;775-778.
8. von der Maase H., Specht L., Jacobsen G.K., et al. Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer. 29A:1993;1931-1934.
9. Oliver R.T.D., Edmonds P.M., Ong J.Y.H., et al. Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma should it be tested in a randomized trial against radiotherapy? Int J Radiat Oncol Biol Phys. 29:1994;3-8.
10. Oliver R.T.D., Lore S., Ong J. Alternatives to radiotherapy in the management of seminoma. Br J Urol. 65:1990;61-67.
11. Horwich A., Dearnaley D.P., Duchesne G.M., et al. Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. J Clin Oncol. 7:1989;1150-1156.
12. Schmoll H.J., Harstrick A., Bokemeyer C., et al. Single-agent carboplatinum for advanced seminoma. A phase II study. Cancer. 72:1993;237-243.
13. Dieckmann K.-P., Krain J., Küster J., et al. Adjuvant carboplatin treatment for seminoma stage I. J Cancer Res Clin Oncol. 122:1996;63-66.
14. Armitage P., Berry G. Statistical Methods in Medical Research. 3rd ed. 1994;Blackwell Scientific, Oxford.
15. Mason M.D., Morrey D., Cole A., et al. Elimination of microscopic metastases from stage I and II seminoma with a single agent, single cycle carboplatin a feasible alternative or adjunct to radiotherapy? Br J Cancer. 74:(suppl 28):1996;15. (abstract).
16. Kratzik C., Kührer I., Wiltschke C., et al. Carboplatin-Monotherapie bei Seminomen im Stadium I. Acta Chir Austriaca. 25:1993;27-28.
17. Krege S., Kalund G., Otto T., et al. Phase II study adjuvant single-agent carboplatin therapy for clinical stage I seminoma . Eur Urol. 31:1997;405-407.
18. Nöst G., Lipsky H., Würnschimmel E. Carboplatinmonotherapie im klinischen Stadium I des Seminoms. Eine akzeptable Alternative? Urologe A. 37:1998;629-634.
19. Speer T.W., Sombeck M.D., Parsons J.T., et al. Testicular seminoma a failure analysis and literature review . Int J Radiat Oncol Biol Phys. 33:1995;89-97.
20. Calvert A.H., Newell D.R., Gumbrell L.A., et al. Carboplatin dosage prospective evaluation of a simple formula based on renal function . J Clin Oncol. 7:1989;1748-1756.
21. Bokemeyer C., Lipp H.-P. Is there a need for pharmacokinetically guided carboplatin dose schedules? Onkologie. 20:1997;343-345.
22. Yao W.Q., Fossa S.D., Dearnaley D.P., et al. Combined single course carboplatin with radiotherapy in treatment of stage IIA, B seminoma - a preliminary report. Radiother Oncol. 33:1994;88-90.
23. Warde P., Gospodarowicz M.K., Banerjee D., et al. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance. J Urol. 157:1997;1705-1710.
24. Verheij M., Dewitt L.G.H., Valdez Olmos R.A., et al. Evidence for a renovascular component in hypertensive patients with late radiation nephropathy. Int J Radiat Oncol Biol Phys. 30:1994;677-683.
25. Jakob A., Kollmannsberger C., Kanz L., et al. Spättoxizität nach Chemotherapie maligner Hodentumoren. Urologe A. 37:1998;635-647.
26. Reiter W.J., Kratzik C., Brodowicz T., et al. Sperm analysis and serum follicle-stimulating hormone levels before and after adjuvant single-agent carboplatin therapy for clinical stage I seminoma. Urology. 52:1998;117-119.
27. Köpf-Maier P. Effects of carboplatin on the testis. A histological study. Cancer Chemother Pharmacol. 29:1992;227-235.
28. Fuse H., Fujiuchi Y., Junicho A., et al. Effect of carboplatin on rat spermatogenesis. Urol Int. 56:1996;219-223.